The effects of dietary taurine supplementation on bone mineral density in ovariectomized rats

Advances in Experimental Medicine and Biology

Volumn 643, Issue , 2009, Pages 341-349

  Choi, Mi Ja ^a   Dimarco, Nancy M ^b  

^a Keimyung University   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CREATININE; OSTEOCALCIN; PHOSPHORUS; TAURINE; WATER;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CONFERENCE PAPER; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FEMUR; IMMUNOASSAY; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OVARIECTOMY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RAT; SPINE; ANIMAL; ARTICLE; DRUG EFFECT; SPRAGUE DAWLEY RAT; WEIGHT GAIN;

RATTUS;

ANIMALS; BONE DENSITY; DIETARY SUPPLEMENTS; FEMALE; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TAURINE; WEIGHT GAIN;

EID: 63149129214     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-75681-3_35     Document Type: Conference Paper

References (25)

1. Booth SL, Tucker KL, Chen H, Hannan MT, Gagnon DG, Cupples LA, Wilson PWF, Ordovas J, Schaefer EJ, Dawson-Hughes B, Kiel DP (2000) Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 71:1201-1208
2. Boujendar S, Reusens B, Merezak S, Ahn M T, Arany E, Hill D, Remacle C (2002) Taurine supplementation to a low protein diet during foetal and early postnatal life restores a normal proliferation and apoptosis of rat pancreatic islets. Diabetologia 45:856-866
3. Chrischilles EA, Butler CD, Davis CS,Wallace RB (1990) A model of lifetime steoporosis impact. Arch Intern Med 151:2026-2032
4. Dolan P, Torgerson DJ (1998) The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 8:611-617
5. Ebeling PR, Jones JD, OFallon WM, Janes CH, Riggs BL. (1993) Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women.J Clin Endocrinol Metab 77:1384-1387
6. Edwards CJ, Hart DJ, Spector TD (2000) Oral ststins and increased bone-mineral density in postmenopausal women. Lancet 355; 2218-2219
7. Furukawa S, Katto M, Kouyama H, Nishida I, Kikumori M, Taniguchi Y, Toda T., Araki H (1991) Repeated dose toxicity study of intravenous treatment with taurine for 13 weeks and recovery test for 5 weeks in rats. Jap Phar Thera 19:275-306
8. Ghiron L, Thompson JL, Holloway L (1995) Effects of recombinant insulin-like growth factor-1 and growth hormone on bone turnover in elderly women. J BoneMiner Res 10:1844-1852
9. Grinspoon SK, Baum HBA, Peterson S, Klibanski A. (1995) Effects of rhIGF-I administration on bone turnover during short-term fasting. J Clin Invest 96:900-906
10. Heaney RP (1993) Nutritional factors in osteoporosis. Annu Rev Nutr 13:287-316
11. Huxtable RJ (1992) Physiological actions of taurine. Physiol. Rev 72:101-163
12. Ilich JZ, Kerstetter JE (2000) Nutrition in bone health revisited: a story beyond calcium.J Am Coll Nutr 19:715-737
13. Jalava T, Sarna S, Pylkkanen L, Mawer B, Kamichael-Davies JA, Adams J, Francis RM, Robinson J, Euge (2003) Association between vertebral fracture and increased mortality in osteoporotic patients. J Bone Miner Res 18:1254-1260
14. Jensen C, Holloway L, Block G, Spiller G, Gildengorin G, Gunderson E, Butterfield G, Marcus R (2002) Long-term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women. Am J Clin Nutr 75:1114-1120
15. Jeri WN (2005) Supplement: women and micronutrients:Addressing the gap throughout the life cycle: Osteoporosis: the role of micronutrients. Am. J. Clinical Nutrition 81:1232S-1239S
16. Melton LJ III (2003) Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res 18:1139-1141
17. Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN (1996) Risk factors for osteoporoticfractures in elderly men. Am J Epidemiol 144:255-263
18. Raisz LJ (1999) Osteoporosis: current approaches and future prospects in diagnosis, pathogenesis and management. J Bone Miner Res 17:79-89
19. Reeves PG, Nielsen FH, Fahey GC (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN 76 A Rodent Diet. J Nutr 123:1939-1951
20. Sjogren K, Liu JL, Blad K (1999) Liver-derived insulin-like growth factor I (IGH-I) is the principal source of IGF-Iin blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96:7088-7092
21. Stafford RS, Brieling RL, Hersh AL (2004) National trends in osteoporosis visits and osteoporosis treatment . Arch Intern Med 164:1525-1530
22. Sturman, G. A (1993) Taurine in development. Physiol. Rev 73:119-147
23. Tangpricha M, Luo C, Fernandez-Estivariz LH, Gu N, Bazargan JM, Klapproth SV, Sitaraman JR, Galloway LM, Leader T R, Ziegler (2006) Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation. JPEN 30:480-486
24. Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PWF, Kiel DP (1999) Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 69:727-736
25. Yakar S, Rosen CJ, Beamer WG (2002) Circulating levels of IGF-1 directly regulatebone growth and density. J ClinInvest 110:771-781